(DIR) Return Create A Forum - Home --------------------------------------------------------- MS Speaks (HTM) https://msspeaks.createaforum.com --------------------------------------------------------- ***************************************************** (DIR) MS Speaks ***************************************************** (DIR) Rebound syndrome in MS patients after stopping Gilenya 6 replies (DIR) More skin cancer reported to FDA from patients on certain oral... 0 replies (DIR) Randomized clinical trial: 2 fingolimod doses vs. Copaxone for... 0 replies (DIR) MS patient on Gilenya with severe COVID-19 reported 0 replies (DIR) (Abst.) Severe COVID-19 infection in patient w/MS treated w/fi... 0 replies (DIR) Gilenya linked to slightly increased cancer risk, Swedish stud... 0 replies (DIR) FDA approves first generics of Gilenya 0 replies (DIR) Fingolimod and liver injury research information (PubMed) 0 replies (DIR) (Abst.) Gilenya vs. Tecfidera in MS... 0 replies (DIR) (Abst.) PML after fingolimod treatment 1 replies ***************************************************** (DIR) Next Page